The ingredient sounds impressive TR987 and the pricing seems alright but I am a bit puzzled as to just how completed phase 2 really is. They of course mention starting phase 3 next years, provided the FDA agrees and sets out the parameters, but I am actually wondering whether you are buying into a company that really is about to start phase 3, or one that is not quite really finished phase 2.
Fair enough question or did I miss something between the lines?
- Forums
- IPOs
- Tissue Repair Therapeutics IPO
The ingredient sounds impressive TR987 and the pricing seems...
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online